Experience & Research
Research Experience:
Nowak RK, Lin C, Chen S, et al. Factors associated with hearing loss in patients with vestibular schwannomas treated with fractionated stereotactic radiotherapy [ASTRO abstract 2145]. Int J Radiat Biol Phys. 2013;87(suppl):S260.
Bennion NR, Nowak RK, Lyden ER, et al. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes. Practical Radiation Oncology. 2016; 6(5), e155-e162.
Powell SF, Gitau MM, Spanos, WC, Jensen AW, Nowak RK, et al. Phase IB study of pembrolizumab in combination with chemoradiotherapy (CRT) for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN). J Clin Oncol 34 (15), 2016 (suppl; abstr TPS6107)
Powell, SF, Gitau MM, Sumey CJ, Reynolds JT, Lohr M, McGraw S, Nowak RK, et al. Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). J Clin Oncol 35, 2017 (suppl; abstr 6011)
Professional Memberships:
American Society for Radiation Oncology (ASTRO)
American College of Radiation Oncology (ACRO)
European Society for Radiotherapy and Oncology (ESTRO)
American Society of Clinical Oncology (ASCO)
American Brachytherapy Society (ABS)
Society for Neuro-Oncology (SNO)
American College of Radiology (ACR)
American Medical Association (AMA)